Drug intelligence / Profile preview

Cretox CP

Development stage: Unknown
Lead developer: Waterley Pharmaceuticals
Administration: Oral

Overview

**Cretox CP** is an oral, Waterley Pharmaceuticals-marketed antioxidant nutritional supplement formulation containing methionine with antioxidant vitamins and trace minerals. The tablet formulation is reported to contain L-methionine, beta-carotene, vitamins C and E, selenium, zinc, and manganese; a sachet formulation contains DL-methionine, beta-carotene, vitamins C and E, and selenium. It is marketed in India for antioxidant and nutritional support, including correction of micronutrient deficiencies, and has been described by pharmacy sources as supportive therapy for pain associated with acute and chronic pancreatitis. Its intended activity is broad reduction of oxidative stress rather than modulation of a defined molecular target.

Brand names: Cretox CP

Beyond the preview

Go deeper on Cretox CP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cretox CP.

Explore the full profile